796073-68-2 = 796073-69-3 反应条件:1.1 Reagents: Dithiothreitol Solvents: Methanol,Ethyl Acetate,Water; 3 H,Ph 7.5,Rt 标题:Semisynthetic Maytansine Analogs For The Targeted Treatment Of Cancer 作者:Widdison,Wayne C.; Wilhelm,Sharon D.; Cavanagh,Emily E.; Whiteman,Kathleen R.; Leece,Barbara A.; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:2006 卷标:49(14) 页码:4392-4408
专利信息
专利号:US-2025127768-A1 优先权日:2022-06-30 标 题:Therapeutic targeting of inositol pyrophosphate synthesis in cancer 发明人:GOLUB TODD; BONDESON DANIEL 权利人:BROAD INST INC 摘要:The subject matter disclosed herein is generally directed to treating cancers sensitive to phosphate dysregulation with inhibitors of inositol pyrophosphate (PP-InsP) synthesis, in particular, inhibitors of inositol hexakisphosphate kinases IP6Ks.
专利号:WO-2023179723-A1 优先权日:2022-03-25 标题:Cleavable fragment directed by affinity fragment, design and synthesis thereof, and use thereof in preparation of site-directed drug conjugate 发明人:HUANG WEI; TANG FENG; ZENG YUE 权利人:SHANGHAI INST MATERIA MEDICA CAS 摘要:Provided in the present invention are a cleavable fragment directed by an affinity fragment, the design and the synthesis thereof, and the use thereof in the preparation of a site-directed drug conjugate. Specifically, provided in the present invention is a conjugate with a ligand affinity directing group. The conjugate is as represented by formula I: AT-CL-R (I), wherein AT is an affinity moiety for a target protein (TP); CL is a cleavable fragment which has a self-cleaving reactivity; and R is a group to be modified to the target protein.
专利号:CN-116836235-A 优先权日:2022-03-25 标 题 :Affinity fragment-directed cleavable fragments, their design, synthesis and application in the preparation of site-directed drug conjugates
专利号:EP-4501945-A1 优先权日:2022-03-25 标 题:Cleavable fragment directed by affinity fragment, design and synthesis thereof, and use thereof in preparation of site-directed drug conjugate
专利号:WO-2024006972-A1 优先权日:2022-06-30 标 题 :Therapeutic targeting of inositol pyrophosphate synthesis in cancer